SciELO - Scientific Electronic Library Online

 
vol.39 número2Treatment of Pompe DiseasePompe disease rehabilitation management índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Journal

Artigo

Indicadores

Links relacionados

  • Em processo de indexaçãoCitado por Google
  • Não possue artigos similaresSimilares em SciELO
  • Em processo de indexaçãoSimilares em Google

Compartilhar


Acta Neurológica Colombiana

versão impressa ISSN 0120-8748versão On-line ISSN 2422-4022

Resumo

MILLAN-PEREZ, Sonia Patricia et al. Pompe's disease: History, epidemiology, pathophysiology and clinical manifestations. Acta Neurol Colomb. [online]. 2023, vol.39, n.2, e5.  Epub 02-Nov-2023. ISSN 0120-8748.  https://doi.org/10.22379/anc.v39i2.1752.

Introduction:

Pompe's disease or glucogenosis type II belongs to the group of metabolic myopathies and is caused by a partial or total deficiency of the acid alpha glucosidase enzyme. The lack/deficiency of this enzyme generates glycogen storage inside the lysosomes in various tissues including skeletal muscle, myocardium and smooth muscle cells. It is a multisystemic disease that can have an early onset or a late onset.

Contents:

In this article, the historical aspects, the pathophysiology and the clinical manifestations of the disease, will be described.

Conclusions:

It is necessary to recognize Pompe disease because this pathology is treatable.

Palavras-chave : Acid maltase deficiency disease; GAA deficiency; Pompe disease; Type II glycogenosis.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )